![Thomas Taapken](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Taapken
Finanzdirektor/CFO bei INFLARX N.V.
Vermögen: 5 005 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Per Svedenhag | M | 66 | 18 Jahre | |
Thomas Kronbach | M | 72 |
elbion AG
![]() elbion AG Miscellaneous Commercial ServicesCommercial Services elbion AG discovers and develops new small molecule drugs for the treatment of inflammatory and central nervous system diseases with high unmet medical need. It's lead product candidate AWD 12-281 is a topical inhibitor and is in phase IIa trials for the treatment of chronic obstructive pulmonary disease and has licensed it to GlaxoSmithKline for exclusive development and commercialization. It focuses on target areas, including PDE inhibitors and CNS modulators, in terms of novel chemistries, novel assays and mechanisms of action, as well as in-house animal disease models. Founded in 2002, the company is headquartered in Radebeul, Germany.
elbion NV
![]() elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | 22 Jahre |
Tord Bertil Lendau | M | 67 |
Scibase AB
| 10 Jahre |
Marie Gérard | F | - |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 9 Jahre |
Nicolas Fulpius | M | 51 | 17 Jahre | |
Stig Gösta Ollmar | M | 78 | 26 Jahre | |
Niels Riedemann | M | 51 | 17 Jahre | |
Renfeng Guo | M | 53 | 17 Jahre | |
Gerd Zettlmeissl | M | 68 | 7 Jahre | |
Helge Lubenow | M | 56 | 8 Jahre | |
Anthony Gibney | M | 53 | 3 Jahre | |
Denis Bedoret | M | 43 |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 4 Jahre |
Diana Ferro | F | 58 | 7 Jahre | |
Richard Brudnick | M | 67 | 5 Jahre | |
Hege Hellstrom | M | 59 | 1 Jahre | |
Mark Kubler | M | 49 | 9 Jahre | |
Ronald Scott | M | 69 | 7 Jahre | |
Maria Habel | M | 41 | 16 Jahre | |
Michael Colérus | M | 62 | 10 Jahre | |
Frank Mathias | M | 62 | 6 Jahre | |
Petra Eßer | F | - | 3 Jahre | |
Nicole Bertsch | F | - | 3 Jahre | |
Alf Laurell | M | - | - | |
Linn Olsen | F | 47 | 4 Jahre | |
Hugues Wallemacq | M | - |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 4 Jahre |
Daniel Walker | M | - | 1 Jahre | |
Daniel Vetter | M | - | 2 Jahre | |
Christian Schmid | M | - | 3 Jahre | |
Tobias Bergenblad | M | 51 | 9 Jahre | |
Pia Renaudin | F | 57 | 1 Jahre | |
Jan Medina | M | - | - | |
Vincent Brichard | M | - |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | - |
Barbro Fridén | M | 68 |
Scibase AB
| - |
Christina Franssen | M | - |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 5 Jahre |
Bruce P. Burnett | M | - | 4 Jahre | |
Erik van den Berg | M | 51 |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | 1 Jahre |
Stefan Yee | M | 62 |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 5 Jahre |
Luc Philips | M | 73 |
elbion NV
![]() elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | - |
Stijn van Rompay | M | 48 |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 12 Jahre |
Camilla Chong | M | 58 | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Merja Tuulikki Karhapää | F | 62 | - | |
Lars Klapproth | M | 56 |
Technical University of Berlin
| 6 Jahre |
Peter John Fellner | M | 80 | 5 Jahre | |
Frank Hieronymi | M | 61 |
Technical University of Berlin
| 8 Jahre |
Pierre Vandepapeliere | M | - |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 4 Jahre |
William Burns | M | 76 | 5 Jahre | |
Matt L. Leavitt | M | - | 3 Jahre | |
Thomas Lennart Eklund | M | 57 | 2 Jahre | |
Jvalini Dwarkasing | M | - | 3 Jahre | |
Florian Schmid | M | 50 | 4 Jahre | |
Philip Nelles | M | 50 |
Technical University of Berlin
| 6 Jahre |
Tong Zhang | M | 64 |
Technical University of Berlin
| 6 Jahre |
Per Gunnar Ernst Aniansson | M | 58 | 5 Jahre | |
Ismail Kola | M | 67 | - | |
Guido Magni | M | 70 | - | |
Achim Plum | M | 55 | 9 Jahre | |
Tilo Torsten Wigand Wolf | M | 60 |
Technical University of Berlin
| 11 Jahre |
Juha Heikki Tapio Jouhki | M | 58 | - | |
Ann Hanham | M | 71 |
Burrill LLC
![]() Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | 13 Jahre |
Uwe Bicker | M | 79 | - | |
Carsten Nils Erik Browall | M | 66 | - | |
David Lemus | M | 61 | 1 Jahre | |
Immo Querner | M | 61 |
Technical University of Berlin
| 7 Jahre |
Bernd Kastler | M | 75 | - | |
Hartwig Grevener | M | 58 |
Technical University of Berlin
| 5 Jahre |
Simon James Grant | M | 57 | - | |
Evan S. Melrose | M | 54 |
Burrill LLC
![]() Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | 2 Jahre |
Michael Sen | M | 55 |
Technical University of Berlin
| 3 Jahre |
Samuel Hendrata Shantiawan | M | - |
Technical University of Berlin
| 4 Jahre |
Claudia Plath | F | 52 |
Technical University of Berlin
| 5 Jahre |
Carsten Heitkamp | M | 60 |
Technical University of Berlin
| 7 Jahre |
Marcus Behrendt | M | - |
Technical University of Berlin
| 6 Jahre |
Peer Reichelt | M | 53 |
Technical University of Berlin
| 7 Jahre |
Oliver Schlink | M | 54 |
Technical University of Berlin
| 4 Jahre |
Olivér Martin | M | - |
Technical University of Berlin
| 1 Jahre |
Christoph Wollny | M | - |
Technical University of Berlin
| 8 Jahre |
Stefan Wintels | M | 58 |
Technical University of Berlin
| 4 Jahre |
Tim Dawidowsky | M | 57 |
Technical University of Berlin
| 4 Jahre |
Michaela Diener | M | - |
Technical University of Berlin
| 3 Jahre |
Thomas Döring | M | 54 |
Technical University of Berlin
| 4 Jahre |
Joachim Rautter | M | 63 |
Technical University of Berlin
| 3 Jahre |
Andreas Klingen | M | 59 |
Technical University of Berlin
| 4 Jahre |
Shanjing Yao | M | 67 |
Technical University of Berlin
| 3 Jahre |
Geert Walther Nygaard | M | - | 5 Jahre | |
Timo Hillebrand | M | - |
Technical University of Berlin
| 5 Jahre |
Marco Kisperth | M | 54 |
Technical University of Berlin
| 4 Jahre |
Solange Olszewska | F | - |
Technical University of Berlin
| 8 Jahre |
Kai Licha | M | 58 |
Technical University of Berlin
| 3 Jahre |
Andreas Gregori | M | 55 |
Technical University of Berlin
| 3 Jahre |
Zsolt Lisziewicz | M | - |
Technical University of Berlin
| 3 Jahre |
Oliver Greve | M | 60 |
Technical University of Berlin
| 6 Jahre |
Christian Rhino | M | 55 |
Technical University of Berlin
| 4 Jahre |
Sigrid Wattler | M | - |
Technical University of Berlin
| 3 Jahre |
Jung Carsten | M | 57 |
Technical University of Berlin
| 6 Jahre |
Christoph Steffens | M | 58 |
Technical University of Berlin
| 5 Jahre |
Mario Hermann Daberkow | M | 55 |
Technical University of Berlin
| 3 Jahre |
Thomas Diepold | M | 59 |
Technical University of Berlin
| 9 Jahre |
Martin Wittig | M | 60 |
Technical University of Berlin
| 3 Jahre |
Konstantin Alfred Winterstein | M | 55 |
Technical University of Berlin
| 4 Jahre |
Matthias Rumpelhardt | M | 64 |
Technical University of Berlin
| 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Deutschland | 64 | 64,00% |
Schweden | 17 | 17,00% |
Belgien | 10 | 10,00% |
Finnland | 9 | 9,00% |
Vereinigte Staaten | 2 | 2,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Thomas Taapken
- Persönliches Netzwerk